55
Participants
Start Date
July 7, 2020
Primary Completion Date
March 7, 2022
Study Completion Date
March 7, 2022
Biocartis Idylla platform - real time PCR detecting EGFR, KRAS and BRAF mutations in liquid based cytology and blood plasma samples
Automated real time PCR mutation analysis - 1. Can the Idylla platform provide a standardised and effective method for detecting EGFR, KRAS and BRAF mutations in blood and liquid based cytology samples for patients with lung and pancreatic cancer. Mutation detection increases the treatment options for patients.
Royal Cornwall Hospital, Truro
Collaborators (1)
Biocartis NV
INDUSTRY
Royal Cornwall Hospitals Trust
OTHER